Donald Huffman

Donald Huffman

Keine laufenden Positionen mehr
79 Jahre
Health Technology
Consumer Services
Finance

Profil

Donald D.
Huffman
served as Chief Financial Officer at Celtrix Pharmaceuticals, Inc. from 1981 to 2000.
Held Chief Financial Officer roles at Sanderling Management CO LLC (2004-2006), Guava Technologies, Inc. (2006-2008), Asante Solutions, Inc. (2008-2010), and WaferGen Bio-systems, Inc. (2010-2012).
Occupied Chief Executive Officer & Chief Financial Officer positions at WaferGen Bio-systems, Inc. from 2010 to 2012.
Served as Director at Aerami Therapeutics, Inc. (2013-2014), SteadyMed Therapeutics, Inc. (2015-2018), and Aerami Therapeutics Holdings, Inc. Also held External Director role at SteadyMed Ltd. (2015-2018).
Chief Executive Officer & Director at Amarantus Bioscience Holdings, Inc. from 2021 to 2025.
Held Chief Financial Officer roles at Merck & Co., Inc., Essential Therapeutics, Inc., Philips Image Guided Therapy Corp., and Genteric, Inc. Education includes undergraduate degree from The Pennsylvania State University and MBA from State University of New York at Buffalo.

Ehemalige bekannte Positionen von Donald Huffman

UnternehmenPositionEnde
AMARANTUS BIOSCIENCE HOLDINGS, INC. Vorstandsvorsitzender 01.10.2025
STEADYMED LTD Direktor/Vorstandsmitglied 30.08.2018
Direktor/Vorstandsmitglied 01.01.2018
WAFERGEN BIO-SYSTEMS, INC. Finanzdirektor/CFO 26.03.2012
ASANTE SOLUTIONS INC Finanzdirektor/CFO 01.09.2010
Sehen Sie sich die Erfahrung von Donald Huffman im Detail an

Ausbildung von Donald Huffman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

32

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Donald Huffman